ArriVent BioPharma, Inc.
$30.17
-0.83 (-2.68%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -1.6%
- 3 Months
- -0.3%
- YTD
- +50.0%
- 1 Year
- +57.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 58.4%
- Largest decline max drawdown, since Aug 2025
- -24.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.06
Own AVBP?
See how AVBP contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.